United States · FDA National Drug Code directory
enoxaparin sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71839-113_c0e38cb8-8aa0-439a-a879-1b54a81ec151
- Product NDC
- 71839-113
- Form
- INJECTION
- Composition / generic term
- enoxaparin sodium
- Labeler
- BE Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230616
- Source listing expiry
- 20271231
Source-listed ingredients
- ENOXAPARIN SODIUM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (71839-113-10) / 1 mL in 1 SYRINGE · 71839-113-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →